myLaurel Valuation, Funding & Investors

myLaurel is valued at $350M as of September 2020.

Last myLaurel valuation

$350M

Series C · Sep 2020

Last myLaurel funding round

$12M

Series A · Jun 2025

Cumulative funding myLaurel raised

$119M

across 5 funding rounds

Key investors in myLaurel

  • City Light Capital
  • GV
  • Deerfield
  • Justin Mateen
  • Frist Cressey Ventures
  • Town Hall Ventures

myLaurel Overview

About myLaurel

myLaurel is a U.S.-based healthcare provider offering in-home acute care, telemedicine, and post-discharge follow-up to prevent hospital readmissions. Operating as Ready Responders, it delivers 16-hour daily whole-person care through in-network partnerships with major insurers. Backed by investors including Google Ventures and Founders Fund, myLaurel serves patients in select markets with programs reducing utilization risks. Services include nurse visits, virtual consultations, and monitoring for chronic conditions, emphasizing home-based alternatives to traditional hospital stays.


Founded

2016

HQ

United StatesNew York City, NY

Status

Privately held

Customer focus

B2C

Revenue model

Services

Valuation

$350M (Sep 2020)

myLaurel Valuation

myLaurel is currently valued at $350M, based on its Series C in September 2020.

The $54M round included Frist Cressey Ventures, Town Hall Ventures, GV, City Light Capital and Deerfield.

myLaurel valuation by funding round

myLaurel valuation by funding round
DateStageValuation
Sep 2020Series C$350M

myLaurel Funding History

myLaurel has raised a total of $119M across 5 funding rounds.

myLaurel's first fundraising round was a $700K seed round in July 2017. The most recent completed round was a $12M Series A in June 2025.

myLaurel funding rounds

myLaurel funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jun 2025Series ADeerfield (lead); GV (lead); Pinta Partners; Emerson Collective; Ochsner Lafayette General$12M-myLaurel is a home-based acute and transitional care provider that delivers hospital-level medical treatment in patient homes through a combination of technology infrastructure and in-market clinical teams. The company's Acute Care at Home model enables hospitals to safely treat complex patients outside traditional inpatient settings, reducing hospital bed strain and generating measurable clinical and financial returns for health system partners. In June 2025, myLaurel closed $12 million in new funding from existing investors, led by Deerfield Management and GV (Google Ventures), with participation from Emerson Collective, Pinta Partners, Ochsner Health, and management. The round was structured as a convertible note, effectively positioning it between seed and Series A funding stages. This capital raise brought myLaurel's cumulative funding to approximately $119.4 million. The company demonstrated strong operational momentum heading into the round, with a record-breaking 2024 and a 4x year-over-year increase in new patient volume and revenue in Q1 2025. myLaurel reported key clinical outcomes including a 49% reduction in hospital readmissions, patient satisfaction scores above 90 NPS, and a six-to-one return on investment for hospital partners. MyLaurel operates primarily through partnerships with major health systems including Ochsner Health, LCMC Health, and Maimonides Medical Center in New York and Louisiana. The company's leadership team includes CEO Juan Vallarino, who brings experience scaling value-based care models, and President and Chief Medical Officer Dr. Marcy Carty. The capital was earmarked to expand the geographic footprint into additional markets, deepen existing health system partnerships, and build clinical infrastructure to support nationwide growth.
Sep 2020Series CFrist Cressey Ventures; Town Hall Ventures; GV; City Light Capital; Deerfield$54M$350MmyLaurel is a tech-enabled healthcare company delivering home-based acute and transitional care to frail, elderly, and medically complex patients. The company provides hospital-level care in patient homes, combining clinical response teams with AI-enabled technology infrastructure that coordinates logistics, documentation, and physician oversight. In September 2020, myLaurel completed a Series C funding round raising $54 million led by multiple prominent healthcare and technology investors including City Light Capital, Deerfield Management, Frist Cressey Ventures, Google Ventures (GV), and Town Hall Ventures. The company's care model demonstrates strong clinical and financial outcomes, including a 49% reduction in readmissions and a six-to-one return on investment for hospital partners. By 2024-2025, myLaurel had expanded operations to major U.S. markets including New York City and New Orleans through partnerships with health systems such as Ochsner Health, LCMC Health, and Maimonides Medical Center, achieving a 4x year-over-year increase in new patient volume and revenue in 2024.
Mar 2020Series BDeerfield (lead); GV (lead); Frist Cressey Ventures; Town Hall Ventures; City Light Capital$48M-myLaurel is a healthcare company providing tech-enabled home-based acute and transitional care, partnering with health systems to deliver hospital-level treatment in patients' homes, reducing readmissions and freeing up hospital capacity. The company operates in markets like New York and Louisiana through partnerships with Ochsner Health, LCMC Health, and Maimonides Medical Center, reporting outcomes such as 49% reduction in readmissions, six-to-one ROI for partners, and patient NPS above 90. Later developments include a $12M round in June 2025 led by Deerfield and GV for expansion, following record 2024 growth with 4x YoY increase in patient volume and revenue, and investments like from SteelSky Ventures to scale in-home acute care platforms.
Dec 2018Series ACity Light Capital (lead); Acumen; Justin Mateen; Acumen America$5M--
Jul 2017SeedMaC Venture Capital; Justin Mateen; Summit Action; City Light Capital$700K--

Who has invested in myLaurel?

13 investors have backed myLaurel across its funding rounds, including City Light Capital, GV, Deerfield, Justin Mateen, Frist Cressey Ventures and Town Hall Ventures.

Lead investors include Deerfield, GV and City Light Capital.


myLaurel Investors

Investors in myLaurel by funding rounds participated
InvestorHQRoundsRoleFirst check
City Light CapitalUnited StatesNew York City, NY4LeadJul 2017
GVUnited StatesSan Francisco, CA3LeadMar 2020
DeerfieldUnited StatesNew York City, NY3LeadMar 2020
Frist Cressey VenturesUnited StatesNashville, TN2ParticipantMar 2020
Town Hall VenturesUnited StatesNew York City, NY2ParticipantMar 2020
Justin MateenUnited StatesUnited States2ParticipantJul 2017
Pinta PartnersUnited StatesNew York City, NY1ParticipantJun 2025
AcumenUnited StatesNew York City, NY1ParticipantDec 2018
Emerson CollectiveUnited StatesSan Francisco, CA1ParticipantJun 2025
MaC Venture CapitalUnited StatesAbilene, TX1ParticipantJul 2017
Summit ActionUnited StatesNew York City, NY1ParticipantJul 2017

This data is available for Pro users. Sign up to see all 13 myLaurel investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

myLaurel Competitors

myLaurel competitors include listed companies like Carriage Services and Angi, and private ones like Snabbit, Aiper, HomeLane and Portea Medical.

Public and private companies comparable to myLaurel
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
SnabbitIndiaMumbaiPrivate$11M-$350M-
AiperChinaShenzhenPrivate--$370M-
HomeLaneIndiaBangalorePrivate$96M-$321M3.3x
Portea MedicalIndiaBangalorePrivate$17M-$267M15.7x
Carriage ServicesUnited StatesUnited StatesPublicly listed$417M$124M$491M2.4x
AngiUnited StatesUnited StatesPublicly listed$1B$114M$215M0.4x

myLaurel Public Comps

myLaurel is still privately-owned, but its public comps include Angi, Carriage Services, HomeMaid, Grupa Klepsydra, K2 LT, Service Corporation International and Rollins.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Angi$1B$114M0.4x0.4x3.7x3.6x
Carriage Services$417M$124M2.5x2.4x8.3x7.7x
HomeMaid$61M$7M1.1x0.9x8.9x8.6x
Grupa Klepsydra$15M$2M3.4x-22.7x-
K2 LT------

This data is available for Pro users. Sign up to see all myLaurel competitors and their valuation data.

Start Free Trial

Common questions about myLaurel

When was myLaurel founded?myLaurel was founded in 2016.
Where is myLaurel headquartered?myLaurel is headquartered in New York City, NY, United States.
Is myLaurel publicly listed?No, myLaurel is a private, VC-backed company.
What is myLaurel's valuation?myLaurel was last valued at $350M in its Series C in September 2020.
How much funding has myLaurel raised?myLaurel has raised $119M across 5 funding rounds.
What was myLaurel's last funding round?myLaurel's last funding round was a $12M Series A in June 2025, led by Deerfield and GV.
Who are myLaurel's investors?myLaurel's investors include City Light Capital, GV, Deerfield, Frist Cressey Ventures, Town Hall Ventures, Justin Mateen, Pinta Partners, Acumen, Emerson Collective, MaC Venture Capital and 3 others.
Which companies are comparable to myLaurel?Companies comparable to myLaurel include Snabbit, Aiper, HomeLane, Portea Medical, Carriage Services and Angi.

See companies similar to myLaurel

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial